ZimVie Inc. (NASDAQ:ZIMV) Shares Sold by Boston Partners

Boston Partners lowered its holdings in ZimVie Inc. (NASDAQ:ZIMV) by 44.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 18,541 shares of the company’s stock after selling 14,919 shares during the quarter. Boston Partners’ holdings in ZimVie were worth $259,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. SG Americas Securities LLC grew its position in ZimVie by 15.7% during the 4th quarter. SG Americas Securities LLC now owns 11,110 shares of the company’s stock worth $155,000 after purchasing an additional 1,508 shares during the period. EMC Capital Management boosted its holdings in ZimVie by 47.0% during the fourth quarter. EMC Capital Management now owns 13,802 shares of the company’s stock worth $193,000 after buying an additional 4,414 shares in the last quarter. Principal Financial Group Inc. grew its position in ZimVie by 9.8% during the fourth quarter. Principal Financial Group Inc. now owns 19,054 shares of the company’s stock valued at $266,000 after buying an additional 1,702 shares during the period. Bailard Inc. increased its holdings in ZimVie by 35.0% in the fourth quarter. Bailard Inc. now owns 21,194 shares of the company’s stock valued at $296,000 after buying an additional 5,494 shares in the last quarter. Finally, Dynamic Technology Lab Private Ltd acquired a new position in shares of ZimVie in the third quarter worth about $470,000. Hedge funds and other institutional investors own 95.63% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Needham & Company LLC restated a “hold” rating on shares of ZimVie in a research note on Thursday, March 13th.

ZimVie Trading Up 0.5 %

Shares of NASDAQ:ZIMV opened at $11.66 on Monday. The business’s 50 day moving average price is $13.31 and its 200-day moving average price is $14.20. ZimVie Inc. has a 1 year low of $11.35 and a 1 year high of $22.40. The firm has a market capitalization of $322.71 million, a price-to-earnings ratio of -0.89 and a beta of 2.10. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.94 and a quick ratio of 1.38.

ZimVie (NASDAQ:ZIMV) last announced its earnings results on Wednesday, February 26th. The company reported $0.27 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.02. ZimVie had a negative net margin of 77.31% and a positive return on equity of 2.90%. The business had revenue of $111.52 million for the quarter, compared to analyst estimates of $113.67 million. On average, equities research analysts forecast that ZimVie Inc. will post 0.6 earnings per share for the current fiscal year.

ZimVie Company Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.